AC Immune (ACIU) Capital Expenditures (2015 - 2025)
AC Immune (ACIU) reported Capital Expenditures of -$133875.2 for Q4 2025, down 30.31% year-over-year from -$192097.3 in Q4 2024, and down 84.64% on a QoQ basis from -$72506.4 in Q3 2025.
AC Immune (ACIU) has 11 years of Capital Expenditures data on file, last reported at -$133875.2 in Q4 2025.
- Quarterly Capital Expenditures fell 30.31% year-over-year to -$133875.2 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.1 million (down 60.96% YoY) and the FY2025 annual result came in at -$1.1 million, down 65.09% from the prior year.
- Capital Expenditures eased to -$133875.2 in Q4 2025 per ACIU's latest filing, from -$72506.4 in the prior quarter.
- Across five years, Capital Expenditures topped out at $4.9 million in Q4 2021 and bottomed at -$873786.7 in Q1 2021.
- The 5-year median for Capital Expenditures is -$205646.8 (2023), against an average of $74110.8.
- The widest annual swing landed in 2022, when Capital Expenditures jumped 76.76%; it then plunged 499.17% in 2025.
- Tracing ACIU's Capital Expenditures over 5 years: stood at $4.9 million in 2021, then tumbled by 48.71% to $2.5 million in 2022, then plunged by 107.4% to -$187140.8 in 2023, then jumped by 45.1% to -$102737.0 in 2024, then sank by 30.31% to -$133875.2 in 2025.
- Per Business Quant, the three latest ACIU Capital Expenditures figures stand at -$133875.2 (Q4 2025), -$72506.4 (Q3 2025), and -$450543.1 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -133,875.17 |
| Dec 31, 2025 | -133,875.17 |
| Sep 30, 2025 | -72,506.35 |
| Sep 30, 2025 | -72,506.35 |
| Jun 30, 2025 | -450,543.06 |
| Jun 30, 2025 | -450,543.06 |
| Mar 31, 2025 | -402,634.69 |
| Mar 31, 2025 | -402,634.69 |
| Dec 31, 2024 | -102,736.97 |
| Dec 31, 2024 | -102,736.97 |
| Sep 30, 2024 | -195,061.02 |
| Sep 30, 2024 | -195,061.02 |
| Jun 30, 2024 | -75,193.96 |
| Jun 30, 2024 | -75,193.96 |
| Mar 31, 2024 | -285,274.90 |
| Mar 31, 2024 | -285,274.90 |
| Dec 31, 2023 | -187,140.84 |
| Dec 31, 2023 | -187,140.84 |
| Sep 30, 2023 | -317,002.72 |
| Sep 30, 2023 | -317,002.72 |
| Jun 30, 2023 | -172,387.21 |
| Jun 30, 2023 | -172,387.21 |
| Mar 31, 2023 | -216,232.52 |
| Mar 31, 2023 | -216,232.52 |
| Dec 31, 2022 | 2.53 Mn |
| Dec 31, 2022 | 2.53 Mn |
| Sep 30, 2022 | -125,290.25 |
| Sep 30, 2022 | -125,290.25 |
| Jun 30, 2022 | -557,563.34 |
| Jun 30, 2022 | -557,563.34 |
| Mar 31, 2022 | -584,716.52 |
| Mar 31, 2022 | -584,716.52 |
| Dec 31, 2021 | 4.93 Mn |
| Dec 31, 2021 | 4.93 Mn |
| Sep 30, 2021 | -539,118.91 |
| Sep 30, 2021 | -539,118.91 |
| Jun 30, 2021 | -688,694.39 |
| Jun 30, 2021 | -688,694.39 |
| Mar 31, 2021 | -873,786.66 |
| Mar 31, 2021 | -873,786.66 |
| Dec 31, 2020 | 2.81 Mn |
| Dec 31, 2020 | 2.81 Mn |
| Sep 30, 2020 | -271,591.37 |
| Sep 30, 2020 | -271,591.37 |
| Jun 30, 2020 | -389,179.46 |
| Jun 30, 2020 | -389,179.46 |
| Mar 31, 2020 | -219,175.48 |
| Mar 31, 2020 | -219,175.48 |
| Dec 31, 2019 | -3.23 Mn |
| Dec 31, 2019 | -3.23 Mn |
| Sep 30, 2019 | 463,832.77 |
| Sep 30, 2019 | 463,832.77 |
| Jun 30, 2019 | 1.36 Mn |
| Jun 30, 2019 | 1.36 Mn |
| Mar 31, 2019 | -513,075.95 |
| Mar 31, 2019 | -513,075.95 |
| Dec 31, 2018 | 3.50 Mn |
| Dec 31, 2018 | 3.50 Mn |
| Sep 30, 2018 | -141,278.09 |
| Sep 30, 2018 | -141,278.09 |
| Jun 30, 2018 | -416,541.53 |
| Jun 30, 2018 | -416,541.53 |
| Mar 31, 2018 | -1.13 Mn |
| Mar 31, 2018 | -1.13 Mn |
| Dec 31, 2017 | 1.82 Bn |
| Dec 31, 2017 | 1.82 Bn |
| Sep 30, 2017 | -1.86 Bn |
| Sep 30, 2017 | -1.86 Bn |
| Jun 30, 2017 | -936,843.80 |
| Jun 30, 2017 | -936,843.80 |
| Mar 31, 2017 | -598,574.05 |
| Mar 31, 2017 | -598,574.05 |
| Dec 31, 2016 | 1.51 Mn |
| Dec 31, 2016 | 1.51 Mn |
| Sep 30, 2016 | -313,686.90 |
| Sep 30, 2016 | -313,686.90 |
| Jun 30, 2016 | -99,971.90 |
| Jun 30, 2016 | -99,971.90 |
| Mar 31, 2016 | -211,452.72 |
| Mar 31, 2016 | -211,452.72 |
| Dec 31, 2015 | 488,086.95 |
| Dec 31, 2015 | 488,086.95 |